1. OP0060 Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data from a Phase 3 Trial. (23rd January 2014) Authors: De Benedetti, F.; Ruperto, N.; Zuber, Z.; Keane, C.; Harari, O.; Kenwright, A.; Cuttica, R.; Keltsev, V.; Xavier, R.; Calvo, I.; Nikishina, I.; Rubio-Pérez, N.; Alekseeva, E.; Chasnyk, V.; Chavez, J.; Horneff, G.; Opoka-Winiarska, V.; Quartier, P.; Silva, C.; Silverman, E. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0291 TOFACITINIB FOR THE TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY. (2nd June 2020) Authors: Ruperto, N.; Synoverska, O.; Ting, T.; Abud-Mendoza, C.; Spindler, A.; Vyzhga, Y.; Marzan, K.; Keltsev, V.; Tirosh, I.; Imundo, L.; Jerath, R.; Kingsbury, D.; Sözeri, B.; Vora, S.; Prahalad, S.; Zholobova, E.; Butbul Aviel, Y.; Chasnyk, V.; Lerman, M.; Nanda, K. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0001 Multicentric Study of Cognitive Impairment in Sle: the Ecles Study. (10th June 2014) Authors: D'Amico, A.; Galván, L.S.; Romero, J.; Arturi, V.; Collado, M.V.; Gόmez, G.; Spindler, A.; Rojas, G.; Fillippin, F.; Vita, L.; Cόrdova, R.; Panόpulos, A.; Khoury, M.C.; García, M.A.; Rodriguez, G.; Carosella, A.; Moreno, C.; Sarano, J.; Barreira, J.C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0160 Clinical and Radiographic Outcomes after 2 Years of Sarilumab in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: van der Heijde, D.; van Adelsberg, J.; Fay, J.; van Hoogstraten, H.; Mangan, E.K.; Graham, N.; Fan, C.; Spindler, A.; Genovese, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0200 Long term safety of filgotinib in the treatment of rheumatoid arthritis: week 108 data from a phase 2b open-label extension study. (12th June 2018) Authors: Westhovens, R.; Alten, R.; Winthrop, K.; Greenwald, M.; Ponce, L.; Enriquez-Sosa, F.; Stanislavchuk, M.; Mazur, M.; Spindler, A.; Cseuz, R.; Nikulenkova, N.; Glowacka-Kulesz, M.; Szombati, I.; Dudek, A.; Mozaffarian, N.; Greer, J.; Kunder, R.; An, D.; Harrison, P.; Van der Aa, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0218 Efficacy and safety of baricitinib in mtx-ir patients with rheumatoid arthritis: 52 week results from a phase 3 study (RA-BALANCE). (12th June 2018) Authors: Li, Z.; Hu, J.; Bao, C.; Li, X.; Li, X.; Xu, J.; Spindler, A.; Zhang, X.; Xu, J.; Li, Z.; Wang, G.; Sun, J.; Ji, F.; Tao, H.; Zhan, L.; Rooney, T.; Zerbini, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0217 Similar efficacy and safety of sarilumab 150 mg or 200 mg q2w regardless of primary (1°) or secondary (2°) failure with tnf inhibitors. (12th June 2018) Authors: Fleischmann, R.; Spindler, A.; Kivitz, A.; Ching, D.; Mangan, E.K.; Kimura, T.; Iglesias-Rodriguez, M.; Burmester, G.R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗